Legend:

• Concept Types
  • target (single disease)
  • classification term
  • pathway-based classification term
  • clinical findings
  • multiple types disease
  • single disease
  • disease type

'Farber Lipogranulomatosis'  (Integration tree)

Pathogenesis

• Genetic disorders of glycan degradation
  • Disorders of sphingolipid metabolism and other lipid storage disorders
    • Sphingolipidosis
      • Other sphingolipidosis
        • Farber Lipogranulomatosis (GDGDB) [ASAH1]
          • Farber Lipogranulomatosis, type 1 [ASAH1]
          • Farber Lipogranulomatosis, type 2 [ASAH1]
          • Farber Lipogranulomatosis, type 3 [ASAH1]
          • Farber Lipogranulomatosis, type 4 [ASAH1]
          • Farber Lipogranulomatosis, type 5 [ASAH1]

Disorders by systems

• Genetic disorders of glycan degradation (by systems, signs and symptoms)
  • Diseases
    • Digestive System Diseases
      • Liver Diseases
        • Hepatomegaly
          • Farber Lipogranulomatosis (GDGDB) [ASAH1]
    • Eye Diseases
      • Retinal Diseases
        • Retinal Degeneration
          • Farber Lipogranulomatosis (GDGDB) [ASAH1]
            • Farber Lipogranulomatosis, type 1 [ASAH1]
            • Farber Lipogranulomatosis, type 5 [ASAH1]
    • Hemic and Lymphatic Diseases
      • Lymphatic Diseases
        • Splenic Diseases
          • Farber Lipogranulomatosis (GDGDB) [ASAH1]
    • Musculoskeletal Diseases
      • Joint Diseases
        • Arthritis
          • Farber Lipogranulomatosis (GDGDB) [ASAH1]
        • Contracture
          • Farber Lipogranulomatosis (GDGDB) [ASAH1]
    • Nervous System Diseases
      • Central Nervous System Diseases
        • Brain Diseases
          • Brain Diseases, Metabolic
            • Brain Diseases, Metabolic, Inborn
              • Farber Lipogranulomatosis (GDGDB) [ASAH1]
      • Neurologic Manifestations
        • Dyskinesias
          • Myoclonus
            • Farber Lipogranulomatosis (GDGDB) [ASAH1]
              • Farber Lipogranulomatosis, type 5 [ASAH1]
        • Neurobehavioral Manifestations
          • Communication Disorders
            • Language Disorders
              • Speech Disorders
                • Farber Lipogranulomatosis (GDGDB) [ASAH1]
                  • Farber Lipogranulomatosis, type 5 [ASAH1]
          • Intellectual Disability
            • Farber Lipogranulomatosis (GDGDB) [ASAH1]
        • Pain
          • Musculoskeletal Pain
            • Farber Lipogranulomatosis (GDGDB) [ASAH1]
        • Paralysis
          • Farber Lipogranulomatosis (GDGDB) [ASAH1]
            • Farber Lipogranulomatosis, type 5 [ASAH1]
        • Seizures
          • Farber Lipogranulomatosis (GDGDB) [ASAH1]
            • Farber Lipogranulomatosis, type 5 [ASAH1]
    • Pathological Conditions, Signs and Symptoms
      • Signs and Symptoms
        • Mobility Limitation
          • Farber Lipogranulomatosis (GDGDB) [ASAH1]
            • Farber Lipogranulomatosis, type 5 [ASAH1]
    • Respiratory Tract Diseases
      • Lung Diseases
        • Farber Lipogranulomatosis (GDGDB) [ASAH1]
          • Farber Lipogranulomatosis, type 1 [ASAH1]
          • Farber Lipogranulomatosis, type 4 [ASAH1]
      • Respiration Disorders
        • Dyspnea
          • Farber Lipogranulomatosis (GDGDB) [ASAH1]
        • Hoarseness
          • Farber Lipogranulomatosis (GDGDB) [ASAH1]
  • Psychiatry and Psychology
    • Mental Disorders
      • Mental Disorders Diagnosed in Childhood
        • Intellectual Disability
          • Farber Lipogranulomatosis (GDGDB) [ASAH1]